Jongeneelen, M.A.

protein binding sars-cov antibody n protein cr 3014 fragment neutralizing coronaviru epitope virus vero cells residue sequence patient domain infection 1 domain peptide 2003. elisa analysis residues 318 syndrome control 318-510 cr 3013 cr 3009 phage presence identi cr 3018 pepscan analysis cr 3014. 318-510 fragments virol neutralization region 2004. identi fied variant sars-cov-infected vero cells cr 3006 igg cr 3009 igg cr 3014 igg 1 mabs biotinylated infectivity virion disease sars-cov infection 565 fragment residues 1 competition elisa speci control igg 3014. sars patients pepscan 293 t cells 100 tcid 50 spike library igg cr 3018 mab cr 3014 sars-cov virions acid substitutions epitope mapping 318-510 fragment fication incubation 37° c antibodies binding lancet binding site fi rst sars coronavirus selection expression clone